(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 5.42% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Adapthealth's revenue in 2025 is $3,240,757,000.On average, 3 Wall Street analysts forecast AHCO's revenue for 2025 to be $437,181,992,001, with the lowest AHCO revenue forecast at $435,929,405,274, and the highest AHCO revenue forecast at $439,014,194,362. On average, 3 Wall Street analysts forecast AHCO's revenue for 2026 to be $467,415,901,610, with the lowest AHCO revenue forecast at $452,119,271,371, and the highest AHCO revenue forecast at $486,327,823,482.
In 2027, AHCO is forecast to generate $518,535,456,916 in revenue, with the lowest revenue forecast at $500,872,333,434 and the highest revenue forecast at $536,198,580,398.